Immunic

Forecast & Rating12 analysts currently cover Immunic, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $42.18, about 163.1% upside from the current price of $16.03. Price targets range from $19.00 to $85.00 — a wide spread, showing clear disagreement over just how much Immunic can rise. For you, this means most professionals who study Immunic closely still see room for the stock to rise. Data as of Aug 17, 2026; for reference only and not investment advice.